The UK has a unique opportunity to position itself as a globally leading environment for healthcare and life sciences innovation. Through agile regulation, strong system connectivity, world-class data assets and early support for innovators, the UK enables faster development, assessment and adoption of innovative technologies — delivering earlier patient access and strengthening its attractiveness for life sciences investment.

This meeting, developed in collaboration with the MHRA, is designed to showcase how the UK ecosystem brings innovation to life across the full pathway: from early development and clinical investigation, through regulation and health technology assessment, to real-world adoption in the NHS.

A particular focus will be placed on artificial intelligence (AI) and digital technologies, given their increasing role across clinical trials, medical devices, in vitro diagnostics (IVDs), real world evidence (RWE) and healthcare delivery.

An exciting programme is currently in development — and registration is now open. Stay tuned for further details to be announced soon.